Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University School of Medicine, Stanford, CA, USA.
Department of Orthopedic Surgery, Stanford University School of Medicine, Stanford, CA, USA.
Theranostics. 2023 Apr 29;13(8):2710-2720. doi: 10.7150/thno.82620. eCollection 2023.
Efficient labeling methods for mesenchymal stem cells (MSCs) are crucial for tracking and understanding their behavior in regenerative medicine applications, particularly in cartilage defects. MegaPro nanoparticles have emerged as a potential alternative to ferumoxytol nanoparticles for this purpose. In this study, we employed mechanoporation to develop an efficient labeling method for MSCs using MegaPro nanoparticles and compared their effectiveness with ferumoxytol nanoparticles in tracking MSCs and chondrogenic pellets. Pig MSCs were labeled with both nanoparticles using a custom-made microfluidic device, and their characteristics were analyzed using various imaging and spectroscopy techniques. The viability and differentiation capacity of labeled MSCs were also assessed. Labeled MSCs and chondrogenic pellets were implanted into pig knee joints and monitored using MRI and histological analysis. MegaPro-labeled MSCs demonstrated shorter T2 relaxation times, higher iron content, and greater nanoparticle uptake compared to ferumoxytol-labeled MSCs, without significantly affecting their viability and differentiation capacity. Post-implantation, MegaPro-labeled MSCs and chondrogenic pellets displayed a strong hypointense signal on MRI with considerably shorter T2* relaxation times compared to adjacent cartilage. The hypointense signal of both MegaPro- and ferumoxytol-labeled chondrogenic pellets decreased over time. Histological evaluations showed regenerated defect areas and proteoglycan formation with no significant differences between the labeled groups. Our study demonstrates that mechanoporation with MegaPro nanoparticles enables efficient MSC labeling without affecting viability or differentiation. MegaPro-labeled cells show enhanced MRI tracking compared to ferumoxytol-labeled cells, emphasizing their potential in clinical stem cell therapies for cartilage defects.
高效的间充质干细胞(MSCs)标记方法对于追踪和了解它们在再生医学应用中的行为至关重要,特别是在软骨缺陷的情况下。MegaPro 纳米颗粒已成为铁氧体纳米颗粒的潜在替代品,用于实现这一目标。在这项研究中,我们采用机械穿孔法,使用 MegaPro 纳米颗粒为 MSCs 开发了一种高效的标记方法,并比较了它们在追踪 MSCs 和软骨形成细胞球方面的效果,Ferumoxytol 纳米颗粒。使用定制的微流控装置对猪 MSCs 进行了两种纳米颗粒的标记,并使用各种成像和光谱技术分析了它们的特性。还评估了标记的 MSCs 的活力和分化能力。将标记的 MSCs 和软骨形成细胞球植入猪膝关节中,并使用 MRI 和组织学分析进行监测。与 Ferumoxytol 标记的 MSCs 相比,MegaPro 标记的 MSCs 表现出较短的 T2 弛豫时间、更高的铁含量和更大的纳米颗粒摄取量,而对其活力和分化能力没有显著影响。植入后,与相邻软骨相比,MegaPro 标记的 MSCs 和软骨形成细胞球在 MRI 上显示出强烈的低信号,T2*弛豫时间明显缩短。两种 MegaPro 和 Ferumoxytol 标记的软骨形成细胞球的低信号随时间逐渐减弱。组织学评估显示再生的缺陷区域和糖胺聚糖形成,标记组之间没有显著差异。我们的研究表明,MegaPro 纳米颗粒的机械穿孔可实现 MSC 的高效标记,而不会影响其活力或分化。与 Ferumoxytol 标记的细胞相比,MegaPro 标记的细胞显示出增强的 MRI 追踪能力,强调了它们在软骨缺陷的临床干细胞治疗中的潜力。
Stem Cell Rev Rep. 2017-2
Pharmaceutics. 2024-12-3
J Pers Med. 2023-11-22
Proc Natl Acad Sci U S A. 2022-2-8
Mater Today Bio. 2021-12-20
Theranostics. 2020-5-15